Climb Bio CLYM Cash Flow Statement (2020-2026)

NASDAQ CLYM
$10.80 +1.07 (+11.00%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Climb Bio Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Climb Bio reported cash from operations of -$10.55M and free cash flow of -$10.55M for the quarter ended Jun 2026, up 5.4% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-9.62M-10.55M-13.20M-14.60M-9.68M-7.76M-22.29M-5.22M-3.97M-3.64M-1.70M-54.89M-8.90M-8.42M-20.78M-8.67M-12.89M-17.52M-13.72M-13.50M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.04M0.03M0.03M0.04M0.03M
Share-based CompensationStock Comp.
1.24M1.15M1.54M1.77M1.78M1.90M10.17M0.78M0.66M1.20M0.47M0.51M2.92M1.66M2.02M1.01M3.98M1.04M1.61M1.48M
Cash from Restructuring
0.20M
Other non-cash itemsOther Non-Cash
0.29M-1.70M-0.11M-0.29M0.08M0.42M0.12M51.73M0.09M0.06M0.05M0.08M-0.02M
Change in Working Capital
Change in Account PayablesChange Payables
0.42M-0.97M-0.56M0.23M0.41M-0.74M0.11M0.01M-0.14M-0.67M0.02M-1.18M-0.22M0.41M0.07M0.09M-0.39M1.79M-1.41M0.20M
Change in Accured ExpensesChange Accured Exp.
-0.62M1.41M0.97M0.50M-1.66M0.61M-1.46M-1.33M-0.49M0.67M-0.75M1.07M0.10M1.02M2.04M-1.09M-0.79M0.22M-1.53M0.94M
Change in Other Operating AssetsOther Assets Change
9.73M-6.04M-0.08M3.00M-4.06M0.26M1.09M1.22M-8.25M-1.55M-0.23M-2.21M1.00M-0.30M-1.88M1.96M1.54M0.71M-0.93M-0.63M
Change in Other Operating LiabilitiesOther Liabilities Change
0.08M0.01M-0.09M-0.14M-0.13M-0.09M-0.02M-0.14M-0.15M-0.12M-0.15M-0.13M-0.04M-0.21M-0.06M-0.05M-0.06M-0.04M-0.06M0.07M
Other Working Capital ChangesOther WC Changes
-9.65M6.05M-0.01M-3.14M3.94M-0.35M-1.11M-1.35M8.11M1.42M0.09M2.08M-1.04M0.09M1.82M-2.01M-1.60M-0.75M0.87M0.70M
Cash from OperationsCash from Ops.
-12.97M-7.88M-10.78M-13.97M-4.18M-8.45M-15.18M-7.97M3.49M-0.95M-1.82M-0.67M-7.56M-5.52M-15.43M-11.15M-12.14M-15.64M-14.38M-10.55M
Investing Activities
Capital ExpendituresCapex
0.11M
Change in Property, Plant and EquipmentChange in PP&E
-0.11M
Purchase of InvestmentsInvestments Purchased
106.92M8.05M25.58M8.93M46.74M6.71M17.45M38.53M2.46M0.00M71.79M60.41M58.75M20.62M23.71M5.00M44.86M82.61M
Sale and Maturity of InvestmentsInvestments Sold
21.55M24.61M55.25M20.99M23.25M36.93M30.50M36.75M13.75M7.00M16.00M25.48M39.08M30.53M31.90M25.60M
Cash from Investing ActivitiesCash from Investing
-106.92M-8.05M-4.04M15.69M8.51M14.28M5.80M-1.60M28.04M36.75M13.75M-9.65M-71.79M-53.41M-42.75M4.79M15.26M25.54M-12.96M-57.26M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
83.14M-83.11M0.00M0.02M0.53M0.29M0.02M2.27M0.04M0.07M0.01M103.70M
Net Shares Issued and RepurchasedNet Shares Issued
83.14M-83.11M0.00M0.02M0.53M0.29M0.02M2.27M0.04M0.07M0.01M103.70M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
83.14M-83.11M0.00M0.02M0.53M0.29M0.02M2.27M0.04M0.07M0.01M103.70M
Cash from Financing ActivitiesCash from Financing
83.14M0.04M0.00M0.02M0.53M0.29M0.02M128.40M2.27M0.04M-0.02M0.01M103.70M
Additional items
Exchange Rate EffectFX Effect
0.08M-0.18M-1.05M-0.99M1.81M0.23M0.40M0.00M-0.33M-0.03M0.02M0.11M-0.06M-0.02M0.02M
Change in Cash
-36.66M-15.90M-14.99M0.67M3.34M7.64M-9.15M-9.14M32.06M35.76M11.92M118.11M-76.97M-58.95M-58.21M-6.34M3.12M9.88M-27.33M35.89M
Ending Cash Balance
62.82M46.92M31.93M32.60M35.94M43.59M34.44M25.29M57.35M93.11M105.03M223.14M146.18M87.23M29.02M22.68M25.80M35.69M8.36M44.25M
Free Cash FlowFCF
-12.97M-7.88M-10.78M-13.97M-4.18M-8.45M-15.18M-7.97M3.49M-0.95M-1.82M-0.67M-7.56M-5.52M-15.43M-11.15M-12.25M-15.64M-14.38M-10.55M
Net Cash FlowNCF
-36.74M-15.90M-14.81M1.72M4.33M5.83M-9.38M-9.54M32.06M36.09M11.95M118.09M-77.07M-58.89M-58.19M-6.36M3.12M9.88M-27.33M35.89M

Climb Bio Cash Flow Statement API

Pull Climb Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLYM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY